Bloomage Non Currrent Assets Other from 2010 to 2025

688363 Stock   49.60  0.85  1.68%   
Bloomage Biotechnology Co's Non Currrent Assets Other are increasing over the years with slightly volatile fluctuation. Non Currrent Assets Other are expected to dwindle to about 266.6 M. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
2019-03-31
Previous Quarter
188.1 M
Current Value
134.6 M
Quarterly Volatility
272.1 M
 
Covid
Check Bloomage Biotechnology Co financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bloomage Biotechnology Co's main balance sheet or income statement drivers, such as Interest Expense of 13 M, Other Operating Expenses of 6.3 B or Net Income Applicable To Common Shares of 562.4 M, as well as many indicators such as . Bloomage financial statements analysis is a perfect complement when working with Bloomage Biotechnology Co Valuation or Volatility modules.
  
This module can also supplement various Bloomage Biotechnology Co Technical models . Check out the analysis of Bloomage Biotechnology Co Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

Bloomage Biotechnology Co financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology Co security.